Tybjærg‐Hansen, Anne

Plasma levels of apolipoprotein Eand risk of dementia in the general population

Rasmussen, K. L., Tybjærg‐Hansen, A., Nordestgaard, B. G., & Frikke‐Schmidt, R. (2015) · Annals of Neurology

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 156

Loss‐of‐function mutation in ABCA1 and risk of Alzheimer's disease and cerebrovascular disease

Nordestgaard, L. T., Tybjærg‐Hansen, A., Nordestgaard, B. G., & Frikke‐Schmidt, R. (2015) · Alzheimer's & Dementia

Alzheimer's disease research and treatmentsLipoproteins and Cardiovascular Health

Cited by 139

Nonfasting triglycerides, cholesterol, and ischemic stroke in the general population

Varbo, A., Nordestgaard, B. G., Tybjærg‐Hansen, A., Schnohr, P., Jensen, G. B., & Benn, M. (2011) · Annals of Neurology

Lipoproteins and Cardiovascular HealthAcute Ischemic Stroke Management

Cited by 122

Plasma apolipoprotein E levels and risk of dementia: A Mendelian randomization study of 106,562 individuals

Rasmussen, K. L., Tybjærg‐Hansen, A., Nordestgaard, B. G., & Frikke‐Schmidt, R. (2018) · Alzheimer's & Dementia

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 75

APOE and dementia – resequencing and genotyping in 105,597 individuals

Rasmussen, K. L., Tybjærg‐Hansen, A., Nordestgaard, B. G., & Frikke‐Schmidt, R. (2020) · Alzheimer's & Dementia

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 64